Eye Movement Tracking to Detect Impairment Due to Acute Cannabis Intoxication
NCT04799093 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225
Last updated 2021-09-13
Summary
The purpose of this study is to determine the accuracy of an impairment algorithm based on eye tracking while watching a short film clip, in comparison to a clinical reference standard of impairment.
Conditions
- Impairment
- Cannabis Intoxication
Interventions
- DIAGNOSTIC_TEST
-
EyeBOX
Eye-Tracking based diagnostic
Sponsors & Collaborators
-
Oculogica, Inc.
lead INDUSTRY
Principal Investigators
-
Rosina Samadani, Ph.D. · Oculogica, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2021-09-07
- Completion
- 2021-09-07
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Neuroscience of Alcohol and Marijuana Impaired Driving
NCT03431987 ·Status: UNKNOWN
-
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT06293040 ·Status: RECRUITING ·Phase: PHASE1
-
Imaging Cannabinoid CB1 Receptors in Alcohol Dependence
NCT00816439 ·Status: COMPLETED
-
Cerebellar Alterations in Individuals With a Cannabis Use Disorder
NCT02816034 ·Status: COMPLETED ·Phase: NA
-
VRT as a Biomarker of Cerebellar Dysfunction in Chronic Cannabis Use
NCT03662737 ·Status: COMPLETED
-
The Neural Correlates of Cannabis Use
NCT03104257 ·Status: COMPLETED
-
Clinical and Neurobiological Effects of Cannabis Dependence in Young Adults
NCT00656487 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Intervention in Alcohol Use Disorder
NCT02168400 ·Status: COMPLETED ·Phase: NA
-
Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse
NCT02616094 ·Status: COMPLETED ·Phase: NA
-
Mitigating the Disinhibiting Effects of Alcohol With Transcranial Magnetic Stimulation
NCT07188376 ·Status: RECRUITING ·Phase: NA
-
Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder
NCT03102918 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence
NCT02210195 ·Status: COMPLETED ·Phase: PHASE2
-
UH3 Varenicline for Cannabis Use Disorder
NCT03980561 ·Status: COMPLETED ·Phase: PHASE2
-
Ambulatory Alcohol Detoxification With Remote Monitoring
NCT03582150 ·Status: WITHDRAWN ·Phase: NA
-
Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder
NCT02932215 ·Status: COMPLETED ·Phase: PHASE1
-
CBD for the Treatment of Alcohol Use Disorder
NCT04873453 ·Status: COMPLETED ·Phase: PHASE2
-
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 3
NCT06669585 ·Status: COMPLETED
-
A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol
NCT04770025 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
NCT03253926 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder
NCT06512389 ·Status: RECRUITING ·Phase: PHASE2
-
Neurofeedback & Alcohol Dependence
NCT02486900 ·Status: COMPLETED ·Phase: NA
-
Cannabinoids and Cerebellar-Motor Functioning
NCT01853020 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prevalence of Chronic Inebriates to the Emergency Department and Suitability for Sobering House Services
NCT01783223 ·Status: COMPLETED
-
Development of LabPatch-alcohol as a Noninvasive Skin Patch to Detect Blood Alcohol Concentrations
NCT03242161 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger
NCT02579317 ·Status: COMPLETED ·Phase: NA